Impact of feed counterion addition and cyclone type on aerodynamic behavior of alginic-atenolol microparticles produced by spray drying
[Display omitted] The inhalatory route has emerged as an interesting non-invasive alternative for drug delivery. This allows both pulmonary (local) and systemic treatments (via alveolar absorption). Further advantages in terms of stability, dose and patient preference have often lead researchers to...
Gespeichert in:
Veröffentlicht in: | European journal of pharmaceutics and biopharmaceutics 2016-12, Vol.109, p.72-80 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 80 |
---|---|
container_issue | |
container_start_page | 72 |
container_title | European journal of pharmaceutics and biopharmaceutics |
container_volume | 109 |
creator | Ceschan, Nazareth Eliana Bucalá, Verónica Ramírez-Rigo, María Verónica Smyth, Hugh David Charles |
description | [Display omitted]
The inhalatory route has emerged as an interesting non-invasive alternative for drug delivery. This allows both pulmonary (local) and systemic treatments (via alveolar absorption). Further advantages in terms of stability, dose and patient preference have often lead researchers to focus on dry powder inhaler delivery systems. Atenolol is an antihypertensive drug with low oral bioavailability and gastrointestinal side effects. Because atenolol possesses adequate permeation across human epithelial membranes, it has been proposed as a good candidate for inhalatory administration. In a previous work, atenolol was combined with alginic acid (AA) and microparticles were developed using spray-drying (SD) technology. Different AA/atenolol ratios, total feed solid content and operative variables were previously explored. In order to improve particle quality for inhalatory administration and the SD yield, in this work the AA acid groups not neutralized by atenolol were kept either free or neutralized to pH∼7 and two different SD cyclones were used. Particle morphology, flow properties, moisture uptake and in vitro aerosolization behavior at different pressure drops were studied. When the AA acid groups were neutralized, particle size decreased as a consequence of the lower feed viscosity. The SD yield and in vitro particle deposition significantly increased when a high performance cyclone was employed, and even when lactose carrier particles were not used. Although the in vitro particle deposition decreased when the storage relative humidity increased, the developed SD powders showed adequate characteristics to be administered by inhalatory route up to storage relative humidities of about 60%. |
doi_str_mv | 10.1016/j.ejpb.2016.09.020 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1835355149</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0939641116306233</els_id><sourcerecordid>1835355149</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-1a8bb6b695693e37b1709e08a35fdf7efa9bd45e90aee7dd70980aba396ae7583</originalsourceid><addsrcrecordid>eNp9UcFu1TAQtBCIPtr-AAfkI5cE-zlOYokLqqBUqsQFztba3hQ_JXawk0r5An4bh9dy5LSr3ZmxZ4eQt5zVnPH2w6nG02zqY-lrpmp2ZC_IgfedqETT8JfkwJRQVdtwfkHe5HxijDWd7F-Ti2PXqk4qeSC_76YZ7ELjQAdER21cw4LJx0DBOb_8bUKZb3aMAemyzUj3GabotgCTt9TgT3j0Me0iMD744G0FC4Y4xpEWQIozpMXbETOdC2215SGz0Twn2KhLmw8PV-TVAGPG66d6SX58-fz95mt1_-327ubTfWWFbJeKQ29Ma1olWyVQdIZ3TCHrQcjBDR0OoIxrJCoGiJ1zZdszMCBUC1i8i0vy_qxbPvJrxbzoyWeL4wgB45o174UUUvJGFejxDC0Gck446Dn5CdKmOdN7APqk9wD0HoBmSpcACundk_5qJnT_KM8XL4CPZwAWl48ek87WYygn8Qntol30_9P_A9MFmr4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1835355149</pqid></control><display><type>article</type><title>Impact of feed counterion addition and cyclone type on aerodynamic behavior of alginic-atenolol microparticles produced by spray drying</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Ceschan, Nazareth Eliana ; Bucalá, Verónica ; Ramírez-Rigo, María Verónica ; Smyth, Hugh David Charles</creator><creatorcontrib>Ceschan, Nazareth Eliana ; Bucalá, Verónica ; Ramírez-Rigo, María Verónica ; Smyth, Hugh David Charles</creatorcontrib><description>[Display omitted]
The inhalatory route has emerged as an interesting non-invasive alternative for drug delivery. This allows both pulmonary (local) and systemic treatments (via alveolar absorption). Further advantages in terms of stability, dose and patient preference have often lead researchers to focus on dry powder inhaler delivery systems. Atenolol is an antihypertensive drug with low oral bioavailability and gastrointestinal side effects. Because atenolol possesses adequate permeation across human epithelial membranes, it has been proposed as a good candidate for inhalatory administration. In a previous work, atenolol was combined with alginic acid (AA) and microparticles were developed using spray-drying (SD) technology. Different AA/atenolol ratios, total feed solid content and operative variables were previously explored. In order to improve particle quality for inhalatory administration and the SD yield, in this work the AA acid groups not neutralized by atenolol were kept either free or neutralized to pH∼7 and two different SD cyclones were used. Particle morphology, flow properties, moisture uptake and in vitro aerosolization behavior at different pressure drops were studied. When the AA acid groups were neutralized, particle size decreased as a consequence of the lower feed viscosity. The SD yield and in vitro particle deposition significantly increased when a high performance cyclone was employed, and even when lactose carrier particles were not used. Although the in vitro particle deposition decreased when the storage relative humidity increased, the developed SD powders showed adequate characteristics to be administered by inhalatory route up to storage relative humidities of about 60%.</description><identifier>ISSN: 0939-6411</identifier><identifier>EISSN: 1873-3441</identifier><identifier>DOI: 10.1016/j.ejpb.2016.09.020</identifier><identifier>PMID: 27697595</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Administration, Inhalation ; Aerosols ; Alginates - administration & dosage ; Alginates - chemistry ; Animals ; Antihypertensive Agents - chemistry ; Atenolol ; Atenolol - administration & dosage ; Atenolol - chemistry ; Desiccation ; Drug Delivery Systems ; Dry Powder Inhalers ; Freeze Drying ; Glucuronic Acid - administration & dosage ; Glucuronic Acid - chemistry ; Hexuronic Acids - administration & dosage ; Hexuronic Acids - chemistry ; Humans ; Hydrogen-Ion Concentration ; In vitro deposition ; Inhalatory administration ; Ionic interaction ; Lactose - chemistry ; Lung - drug effects ; Microscopy, Electron, Scanning ; Microspheres ; Particle Size ; Powders ; Pressure ; Spray-drying ; Viscosity</subject><ispartof>European journal of pharmaceutics and biopharmaceutics, 2016-12, Vol.109, p.72-80</ispartof><rights>2016 Elsevier B.V.</rights><rights>Copyright © 2016 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-1a8bb6b695693e37b1709e08a35fdf7efa9bd45e90aee7dd70980aba396ae7583</citedby><cites>FETCH-LOGICAL-c356t-1a8bb6b695693e37b1709e08a35fdf7efa9bd45e90aee7dd70980aba396ae7583</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0939641116306233$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27697595$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ceschan, Nazareth Eliana</creatorcontrib><creatorcontrib>Bucalá, Verónica</creatorcontrib><creatorcontrib>Ramírez-Rigo, María Verónica</creatorcontrib><creatorcontrib>Smyth, Hugh David Charles</creatorcontrib><title>Impact of feed counterion addition and cyclone type on aerodynamic behavior of alginic-atenolol microparticles produced by spray drying</title><title>European journal of pharmaceutics and biopharmaceutics</title><addtitle>Eur J Pharm Biopharm</addtitle><description>[Display omitted]
The inhalatory route has emerged as an interesting non-invasive alternative for drug delivery. This allows both pulmonary (local) and systemic treatments (via alveolar absorption). Further advantages in terms of stability, dose and patient preference have often lead researchers to focus on dry powder inhaler delivery systems. Atenolol is an antihypertensive drug with low oral bioavailability and gastrointestinal side effects. Because atenolol possesses adequate permeation across human epithelial membranes, it has been proposed as a good candidate for inhalatory administration. In a previous work, atenolol was combined with alginic acid (AA) and microparticles were developed using spray-drying (SD) technology. Different AA/atenolol ratios, total feed solid content and operative variables were previously explored. In order to improve particle quality for inhalatory administration and the SD yield, in this work the AA acid groups not neutralized by atenolol were kept either free or neutralized to pH∼7 and two different SD cyclones were used. Particle morphology, flow properties, moisture uptake and in vitro aerosolization behavior at different pressure drops were studied. When the AA acid groups were neutralized, particle size decreased as a consequence of the lower feed viscosity. The SD yield and in vitro particle deposition significantly increased when a high performance cyclone was employed, and even when lactose carrier particles were not used. Although the in vitro particle deposition decreased when the storage relative humidity increased, the developed SD powders showed adequate characteristics to be administered by inhalatory route up to storage relative humidities of about 60%.</description><subject>Administration, Inhalation</subject><subject>Aerosols</subject><subject>Alginates - administration & dosage</subject><subject>Alginates - chemistry</subject><subject>Animals</subject><subject>Antihypertensive Agents - chemistry</subject><subject>Atenolol</subject><subject>Atenolol - administration & dosage</subject><subject>Atenolol - chemistry</subject><subject>Desiccation</subject><subject>Drug Delivery Systems</subject><subject>Dry Powder Inhalers</subject><subject>Freeze Drying</subject><subject>Glucuronic Acid - administration & dosage</subject><subject>Glucuronic Acid - chemistry</subject><subject>Hexuronic Acids - administration & dosage</subject><subject>Hexuronic Acids - chemistry</subject><subject>Humans</subject><subject>Hydrogen-Ion Concentration</subject><subject>In vitro deposition</subject><subject>Inhalatory administration</subject><subject>Ionic interaction</subject><subject>Lactose - chemistry</subject><subject>Lung - drug effects</subject><subject>Microscopy, Electron, Scanning</subject><subject>Microspheres</subject><subject>Particle Size</subject><subject>Powders</subject><subject>Pressure</subject><subject>Spray-drying</subject><subject>Viscosity</subject><issn>0939-6411</issn><issn>1873-3441</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9UcFu1TAQtBCIPtr-AAfkI5cE-zlOYokLqqBUqsQFztba3hQ_JXawk0r5An4bh9dy5LSr3ZmxZ4eQt5zVnPH2w6nG02zqY-lrpmp2ZC_IgfedqETT8JfkwJRQVdtwfkHe5HxijDWd7F-Ti2PXqk4qeSC_76YZ7ELjQAdER21cw4LJx0DBOb_8bUKZb3aMAemyzUj3GabotgCTt9TgT3j0Me0iMD744G0FC4Y4xpEWQIozpMXbETOdC2215SGz0Twn2KhLmw8PV-TVAGPG66d6SX58-fz95mt1_-327ubTfWWFbJeKQ29Ma1olWyVQdIZ3TCHrQcjBDR0OoIxrJCoGiJ1zZdszMCBUC1i8i0vy_qxbPvJrxbzoyWeL4wgB45o174UUUvJGFejxDC0Gck446Dn5CdKmOdN7APqk9wD0HoBmSpcACundk_5qJnT_KM8XL4CPZwAWl48ek87WYygn8Qntol30_9P_A9MFmr4</recordid><startdate>201612</startdate><enddate>201612</enddate><creator>Ceschan, Nazareth Eliana</creator><creator>Bucalá, Verónica</creator><creator>Ramírez-Rigo, María Verónica</creator><creator>Smyth, Hugh David Charles</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201612</creationdate><title>Impact of feed counterion addition and cyclone type on aerodynamic behavior of alginic-atenolol microparticles produced by spray drying</title><author>Ceschan, Nazareth Eliana ; Bucalá, Verónica ; Ramírez-Rigo, María Verónica ; Smyth, Hugh David Charles</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-1a8bb6b695693e37b1709e08a35fdf7efa9bd45e90aee7dd70980aba396ae7583</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Administration, Inhalation</topic><topic>Aerosols</topic><topic>Alginates - administration & dosage</topic><topic>Alginates - chemistry</topic><topic>Animals</topic><topic>Antihypertensive Agents - chemistry</topic><topic>Atenolol</topic><topic>Atenolol - administration & dosage</topic><topic>Atenolol - chemistry</topic><topic>Desiccation</topic><topic>Drug Delivery Systems</topic><topic>Dry Powder Inhalers</topic><topic>Freeze Drying</topic><topic>Glucuronic Acid - administration & dosage</topic><topic>Glucuronic Acid - chemistry</topic><topic>Hexuronic Acids - administration & dosage</topic><topic>Hexuronic Acids - chemistry</topic><topic>Humans</topic><topic>Hydrogen-Ion Concentration</topic><topic>In vitro deposition</topic><topic>Inhalatory administration</topic><topic>Ionic interaction</topic><topic>Lactose - chemistry</topic><topic>Lung - drug effects</topic><topic>Microscopy, Electron, Scanning</topic><topic>Microspheres</topic><topic>Particle Size</topic><topic>Powders</topic><topic>Pressure</topic><topic>Spray-drying</topic><topic>Viscosity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ceschan, Nazareth Eliana</creatorcontrib><creatorcontrib>Bucalá, Verónica</creatorcontrib><creatorcontrib>Ramírez-Rigo, María Verónica</creatorcontrib><creatorcontrib>Smyth, Hugh David Charles</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of pharmaceutics and biopharmaceutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ceschan, Nazareth Eliana</au><au>Bucalá, Verónica</au><au>Ramírez-Rigo, María Verónica</au><au>Smyth, Hugh David Charles</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Impact of feed counterion addition and cyclone type on aerodynamic behavior of alginic-atenolol microparticles produced by spray drying</atitle><jtitle>European journal of pharmaceutics and biopharmaceutics</jtitle><addtitle>Eur J Pharm Biopharm</addtitle><date>2016-12</date><risdate>2016</risdate><volume>109</volume><spage>72</spage><epage>80</epage><pages>72-80</pages><issn>0939-6411</issn><eissn>1873-3441</eissn><abstract>[Display omitted]
The inhalatory route has emerged as an interesting non-invasive alternative for drug delivery. This allows both pulmonary (local) and systemic treatments (via alveolar absorption). Further advantages in terms of stability, dose and patient preference have often lead researchers to focus on dry powder inhaler delivery systems. Atenolol is an antihypertensive drug with low oral bioavailability and gastrointestinal side effects. Because atenolol possesses adequate permeation across human epithelial membranes, it has been proposed as a good candidate for inhalatory administration. In a previous work, atenolol was combined with alginic acid (AA) and microparticles were developed using spray-drying (SD) technology. Different AA/atenolol ratios, total feed solid content and operative variables were previously explored. In order to improve particle quality for inhalatory administration and the SD yield, in this work the AA acid groups not neutralized by atenolol were kept either free or neutralized to pH∼7 and two different SD cyclones were used. Particle morphology, flow properties, moisture uptake and in vitro aerosolization behavior at different pressure drops were studied. When the AA acid groups were neutralized, particle size decreased as a consequence of the lower feed viscosity. The SD yield and in vitro particle deposition significantly increased when a high performance cyclone was employed, and even when lactose carrier particles were not used. Although the in vitro particle deposition decreased when the storage relative humidity increased, the developed SD powders showed adequate characteristics to be administered by inhalatory route up to storage relative humidities of about 60%.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>27697595</pmid><doi>10.1016/j.ejpb.2016.09.020</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0939-6411 |
ispartof | European journal of pharmaceutics and biopharmaceutics, 2016-12, Vol.109, p.72-80 |
issn | 0939-6411 1873-3441 |
language | eng |
recordid | cdi_proquest_miscellaneous_1835355149 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Administration, Inhalation Aerosols Alginates - administration & dosage Alginates - chemistry Animals Antihypertensive Agents - chemistry Atenolol Atenolol - administration & dosage Atenolol - chemistry Desiccation Drug Delivery Systems Dry Powder Inhalers Freeze Drying Glucuronic Acid - administration & dosage Glucuronic Acid - chemistry Hexuronic Acids - administration & dosage Hexuronic Acids - chemistry Humans Hydrogen-Ion Concentration In vitro deposition Inhalatory administration Ionic interaction Lactose - chemistry Lung - drug effects Microscopy, Electron, Scanning Microspheres Particle Size Powders Pressure Spray-drying Viscosity |
title | Impact of feed counterion addition and cyclone type on aerodynamic behavior of alginic-atenolol microparticles produced by spray drying |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T13%3A32%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Impact%20of%20feed%20counterion%20addition%20and%20cyclone%20type%20on%20aerodynamic%20behavior%20of%20alginic-atenolol%20microparticles%20produced%20by%20spray%20drying&rft.jtitle=European%20journal%20of%20pharmaceutics%20and%20biopharmaceutics&rft.au=Ceschan,%20Nazareth%20Eliana&rft.date=2016-12&rft.volume=109&rft.spage=72&rft.epage=80&rft.pages=72-80&rft.issn=0939-6411&rft.eissn=1873-3441&rft_id=info:doi/10.1016/j.ejpb.2016.09.020&rft_dat=%3Cproquest_cross%3E1835355149%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1835355149&rft_id=info:pmid/27697595&rft_els_id=S0939641116306233&rfr_iscdi=true |